What is AMD

Dis­ease patho­logy

Age-Re­lated Mac­ula De­gen­er­a­tion (AMD) is a ma­jor cause of blind­ness in eld­erly people in in­dus­tri­al­ised coun­tries. You can dis­tin­guish the at­roph­ic (“dry”) and the ex­ud­at­ive (“wet”) form, which is the more dev­ast­at­ing one.

What is AMD

Cur­rent treat­ment

The state of the art of wet AMD treat­ment makes use of drugs that bind to the VEGF or com­par­able mo­lecules to in­hib­it ves­sel growth. Cur­rently on the mar­ket are Avas­tin, ® Eylea®, Lu­centis®, Beovu®, Vabysmo®, and Sus­vimoTM.